CEE drug markets have good development potential, says report
This article was originally published in Scrip
Executive Summary
Pharmaceutical and medical device markets in countries of central and eastern Europe are 1.5-5-fold smaller than those in western Europe, but they have not yet developed to their full potential, says a new report from Frost & Sullivan.